Skip to content

Clinical trials

Approved for marketing Expanded access Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Expanded access Status: Approved for marketing Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

No trials to chart.

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jeanne Link1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Jonsson Comprehensive Cancer Center1
Merus B.V.1
Stanford University1
University of California, San Francisco1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms7
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Cholangiocarcinoma1
Colorectal Neoplasms1
Genital Diseases, Male1
Genital Neoplasms, Male1
Head and Neck Neoplasms1
Neoplasms, Unknown Primary1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.